Health Care Related Organization
Bristol Myers Squibb and Kyowa Kirin Announce New Rounds of Layoffs in New Jersey
Pharmaceutical layoffs, workforce reduction, cost-cutting measures, Bristol Myers Squibb, Kyowa Kirin, New Jersey pharma industry
Pharmaceutical Industry Warns of Drug Shortages and Price Hikes Due to Trump’s New Tariffs
Trump tariffs, drug shortages, price increases, pharmaceutical industry, trade groups, supply chain disruption, generic drugs, active pharmaceutical ingredients (APIs)
Pfizer Exceeds Q4 Expectations: COVID-19 Products and Cost-Cutting Drive Strong Performance
Pfizer, Q4 earnings, COVID-19 portfolio, cost-cutting initiatives, revenue growth, Paxlovid, financial recovery, 2025 guidance
Astellas Pharma Announces Major Management Restructuring Amid Strong Financial Performance
Astellas Pharma, management restructuring, financial results, executive appointments, pharmaceutical industry
FDA Approves Roche’s PATHWAY HER2 Test for HER2-Ultralow Metastatic Breast Cancer
Roche, PATHWAY HER2 (4B5) test, FDA approval, HER2-ultralow, metastatic breast cancer, companion diagnostic, Enhertu, personalized medicine
CDC Orders Retraction of Research Papers and Removes Website Content Amid New Language Restrictions
CDC, research retraction, website content removal, language restrictions, LGBTQ, gender identity, scientific publications
Trump’s Tariffs Threaten to Disrupt Healthcare Supply Chain and Increase Costs
Trump tariffs, medical supply chain, healthcare costs, drug shortages, medical devices, pharmaceutical industry, import taxes
Novartis Reports Strong Financial Performance in 2024, Validating Pure-Play Strategy
Novartis, earnings, pure-play strategy, pharmaceutical industry, financial performance, R&D focus, core therapeutic areas
GLP-1 Weight Loss Drugs Make Super Bowl Advertising Debut Amid Shifting Health Marketing Landscape
GLP-1, Super Bowl ads, Hims & Hers, weight loss drugs, pharmaceutical marketing, healthcare advertising, obesity epidemic
AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction
AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry